Bali Muralidhar

OKUR

Bali Muralidhar serves as Director at OnKure Therapeutics, Inc. (OKUR). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

9 trades

$5.19M

Total Sells

0 trades

$0.00

Net Position

Net Buyer

$5.19M

Companies Traded

XCUR, OKUR

Active Period

Apr 2021 – May 2022

9 total trades

Most Recent

Buy XCUR

May 19, 2022 · $285.2K

Bali Muralidhar's Insider Trading at OnKure Therapeutics, Inc. (OKUR)

Buys

8 · $4.90M

Sells

0 · $0.00

Total Shares Bought

415,731

Total Shares Sold

OKUR Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Jul 15, 2021	Buy	111,736	$8.50	$949.8K	2,073,957
Jun 25, 2021	Buy	20,710	$9.28	$192.2K	1,962,221
Jun 23, 2021	Buy	47,274	$8.94	$422.4K	1,941,511
Jun 10, 2021	Buy	16,605	$9.50	$157.7K	1,894,237
Jun 7, 2021	Buy	12,357	$9.26	$114.4K	1,877,632
Jun 2, 2021	Buy	14	$9.50	$133.00	1,865,275
May 28, 2021	Buy	7,035	$9.36	$65.9K	1,865,261
Apr 15, 2021	Buy	200,000	$15.00	$3.00M	1,858,226

Bali Muralidhar's Insider Trading at Exicure, Inc. (XCUR)

Buys

1 · $285.2K

Sells

0 · $0.00

Total Shares Bought

1,472,126

Total Shares Sold

XCUR Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
May 19, 2022	Buy	1,472,126	$0.19	$285.2K	8,449,126

Related Insiders

Jason A. Leverone

officer: Chief Financial Officer

OKURSell · Mar 24, 2026

Nicholas A Saccomano

President and CEO

OKURSell · Mar 24, 2026

Josh Miller

Chief Accounting Officer

XCURSell · Feb 16, 2026

Exicure HiTron Inc.

10 percent owner

XCURSell · Jan 21, 2026

SANGSANGIN INVESTMENT & SECURITIES CO., LTD.

XCURSell · Dec 10, 2025

Explore More Insider Trading Data

OKUR Insider Trading Activity

View all insider trades at OnKure Therapeutics, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity